Who we are

Our purpose

We reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.

Our culture (Icon)

Our culture

  • Curious
  • Inspired
  • Unbossed
Our values (Icon)

Our values

  • Innovation
  • Performance
  • Quality
  • Courage
  • Collaboration
  • Integrity

Our company

At Novartis, we use science-based innovation to adress some of society‘s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.

Click to explore

Innovative Medicines

The Innovative Medicines Division has two business units:

Novartis Oncology

Novartis Oncology focuses on patented treatments for a variety of cancers and rare diseases.

Novartis Pharmaceuticals

Novartis Pharmaceuticals focuses on patented treatments in multiple disease areas to enhance health outcomes for patients and off er solutions to healthcare providers.

Sandoz

Sandoz offers patients and healthcare professionals high-quality, affordable generics and biosimilars.

Novartis Business services (NBS)

consolidates support services across our organization, helping drive efficiency, simplification, standardization and quality.

Novartis technical operations (NTO)

is responsible for making our innovative medicines, devices and Sandoz products and delivering them to our customers across the world.

Corporate functions

support the enterprise in specific areas of expertise, including finance, human resources, legal and communications.

Research and development (R&D)

The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis. NIBR focuses on discovering new drugs that can change the practice of medicine.

The Global Drug Development (GDD) organization oversees the development of new medicines discovered by our researchers and partners.

Our people

The greatest strength of Novartis is our people, whose diversity, energy and creativity are crucial to our success.

Our People (Graphic)

Headcount

108 775

Nationalities

149

Annual training hours per employee

35.8

Women in management

44%